NeuroPace, Inc. (NPCE) Revenue History
NeuroPace, Inc. (NPCE) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $45.18M |
| 2022-12-31 | $45.52M |
| 2023-12-31 | $65.42M |
| 2024-12-31 | $79.91M |
| 2025-12-31 | $99.99M |
How NPCE compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| OSUR | OraSure Technologies Inc. | $115.02M |
| AGEN | Agenus Inc. | $114.20M |
| HBIO | Harvard Bioscience Inc. | $86.55M |
| ETON | Eton Pharmaceuticals Inc. | $79.95M |
| RMTI | Rockwell Medical Inc. | $69.26M |
These are five companies in the same sector as NPCE with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get NeuroPace, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("NPCE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NPCE | $14.78 | +1.51% | 0.06M |
| 3 | ||||
| 4 | ||||
| 5 |